PSTV (Plus Therapeutics) Cyclically Adjusted Book per Share: $487.41 (As of Mar. 2026)


PSTV Plus Therapeutics Inc PSTV
26 GF Score
Price $4.23
! 2 Warning Signs
View Full Analysis

What is Plus Therapeutics Cyclically Adjusted Book per Share?

Plus Therapeutics PSTV -1.41% 26 Cyclically Adjusted Book per Share is $487.41 as of Mar. 2026. GuruFocus rates PSTV with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Plus Therapeutics's adjusted book value per share for the three months ended in Mar. 2026 was $1.743. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $487.41 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Plus Therapeutics's average Cyclically Adjusted Book Growth Rate was -10.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -13.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Plus Therapeutics was -13.30% per year. The lowest was -46.30% per year. And the median was -14.10% per year.

As of today (2026-06-28), Plus Therapeutics's current stock price is $4.23. Plus Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $487.41. Plus Therapeutics's Cyclically Adjusted PB Ratio of today is 0.01.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Plus Therapeutics was 2.51. The lowest was 0.01. And the median was 0.19.


Plus Therapeutics  (NAS:PSTV) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Plus Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.23/487.41
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Plus Therapeutics was 2.51. The lowest was 0.01. And the median was 0.19.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Plus Therapeutics Cyclically Adjusted Book per Share Related Terms


Plus Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Plus Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plus Therapeutics Cyclically Adjusted Book per Share Chart

Plus Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 875.41 759.29 644.72 556.60 494.21

Plus Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 541.82 527.01 512.40 494.21 487.41

PSTV vs GRCE, NNVC, ATNM: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Plus Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Plus Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Plus Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Plus Therapeutics's Cyclically Adjusted PB Ratio falls into.


PSTV
26GF Score
Plus Therapeutics Inc PSTV
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Plus Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Plus Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.743/330.2130*330.2130
=1.743

Current CPI (Mar. 2026) = 330.2130.

Plus Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 241.018 0.000
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 0.000 246.524 0.000
201803 0.000 249.554 0.000
201806 0.000 251.989 0.000
201809 6,138.000 252.439 8,029.058
201812 5,225.000 251.233 6,867.581
201903 3,857.000 254.202 5,010.313
201906 -6,276.000 256.143 -8,090.859
201909 20.000 256.759 25.722
201912 116.000 256.974 149.061
202003 8.500 258.115 10.874
202006 300.000 257.797 384.271
202009 218.417 260.280 277.102
202012 168.389 260.474 213.473
202103 352.333 264.877 439.241
202106 373.281 271.696 453.677
202109 359.878 274.310 433.219
202112 264.293 278.802 313.029
202203 248.169 287.504 285.035
202206 161.317 296.311 179.774
202209 131.080 296.808 145.833
202212 71.611 296.797 79.674
202303 27.875 301.836 30.496
202306 23.148 305.109 25.053
202309 14.486 307.789 15.541
202312 -7.573 306.746 -8.152
202403 -28.287 312.332 -29.906
202406 -33.443 314.175 -35.150
202409 -21.924 315.301 -22.961
202412 -37.919 315.605 -39.674
202503 -34.766 319.799 -35.898
202506 0.823 322.561 0.843
202509 0.960 324.800 0.976
202512 0.720 324.054 0.734
202603 1.743 330.213 1.743

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $487.41 mean?
Plus Therapeutics (PSTV) has a Cyclically Adjusted Book per Share of $487.41 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Plus Therapeutics and its competitors.
Is Plus Therapeutics' Cyclically Adjusted Book per Share too high?
Plus Therapeutics' current Cyclically Adjusted Book per Share is $487.41. Overall, Plus Therapeutics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Plus Therapeutics' Cyclically Adjusted Book per Share compare to GRCE and NNVC?
Plus Therapeutics' Cyclically Adjusted Book per Share of $487.41 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Plus Therapeutics and its competitors. Plus Therapeutics's current Cyclically Adjusted Book per Share is $487.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plus Therapeutics stock overvalued right now?
Plus Therapeutics (PSTV) has a current Cyclically Adjusted Book per Share of $487.41. The current Cyclically Adjusted Book per Share is $487.41. Plus Therapeutics' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Plus Therapeutics (PSTV), the current Cyclically Adjusted Book per Share is $487.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Plus Therapeutics Business Description

Other Exchanges XMP1:Germany
Address 6420 Levit Green Boulevard, Suite 210, Houston, TX, USA, 77021
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
26GF Score

Get the complete analysis for PSTV

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.23
Price